Related references
Note: Only part of the references are listed.Cocaine-induced endocannabinoid release modulates behavioral and neurochemical sensitization in mice
Maddalena Mereu et al.
ADDICTION BIOLOGY (2015)
Parsing the players: 2-arachidonoylglycerol synthesis and degradation in the CNS
N. Murataeva et al.
BRITISH JOURNAL OF PHARMACOLOGY (2014)
More surprises lying ahead. The endocannabinoids keep us guessing
Daniele Piomelli
NEUROPHARMACOLOGY (2014)
Prior Exposure to THC Increases the Addictive Effects of Nicotine in Rats
Leigh V. Panlilio et al.
NEUROPSYCHOPHARMACOLOGY (2013)
Chemical Probes of Endocannabinoid Metabolism
Jacqueline L. Blankman et al.
PHARMACOLOGICAL REVIEWS (2013)
Characterization of the Effects of Reuptake and Hydrolysis Inhibition on Interstitial Endocannabinoid Levels in the Brain: An in Vivo Microdialysis Study
Joost Wiskerke et al.
ACS CHEMICAL NEUROSCIENCE (2012)
A catalytically silent FAAH-1 variant drives anandamide transport in neurons
Jin Fu et al.
NATURE NEUROSCIENCE (2012)
Cannabinoid facilitation of behavioral and biochemical hedonic taste responses
M. A. De Luca et al.
NEUROPHARMACOLOGY (2012)
Endocannabinoid tone versus constitutive activity of cannabinoid receptors
Allyn C. Howlett et al.
BRITISH JOURNAL OF PHARMACOLOGY (2011)
Differential effect of opioid and cannabinoid receptor blockade on heroin-seeking reinstatement and cannabinoid substitution in heroin-abstinent rats
L. Fattore et al.
BRITISH JOURNAL OF PHARMACOLOGY (2011)
The Endogenous Cannabinoid 2-Arachidonoylglycerol Is Intravenously Self-Administered by Squirrel Monkeys
Zuzana Justinova et al.
JOURNAL OF NEUROSCIENCE (2011)
Endocannabinoid-mediated synaptic plasticity and addiction-related behavior
Nimish Sidhpura et al.
NEUROPHARMACOLOGY (2011)
NEUROCHEMICAL BASIS OF CANNABIS ADDICTION
R. Maldonado et al.
NEUROSCIENCE (2011)
Supply and demand for endocannabinoids
Bradley E. Alger et al.
TRENDS IN NEUROSCIENCES (2011)
Blockade of Endocannabinoid Hydrolytic Enzymes Attenuates Precipitated Opioid Withdrawal Symptoms in Mice
Divya Ramesh et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2011)
Involvement of 2-arachidonoyl glycerol in the increased consumption of and preference for ethanol of mice treated with neurotoxic doses of methamphetamine
M. D. Gutierrez-Lopez et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
Inhibitors of Endocannabinoid-Metabolizing Enzymes Reduce Precipitated Withdrawal Responses in THC-Dependent Mice
Joel E. Schlosburg et al.
AAPS JOURNAL (2009)
Characterization of Monoacylglycerol Lipase Inhibition Reveals Differences in Central and Peripheral Endocannabinoid Metabolism
Jonathan Z. Long et al.
CHEMISTRY & BIOLOGY (2009)
Endocannabinoid chemical biology: a tool for the development of novel therapies
Stefania Petrosino et al.
CURRENT OPINION IN CHEMICAL BIOLOGY (2009)
Fatty acid amide hydrolase as a potential therapeutic target for the treatment of pain and CNS disorders
Kay Ahn et al.
EXPERT OPINION ON DRUG DISCOVERY (2009)
Environmental Enrichment Reduces Cocaine Seeking and Reinstatement Induced by Cues and Stress but Not by Cocaine
Claudia Chauvet et al.
NEUROPSYCHOPHARMACOLOGY (2009)
Fatty Acid Amide Hydrolase Inhibition Heightens Anandamide Signaling Without Producing Reinforcing Effects in Primates
Zuzana Justinova et al.
BIOLOGICAL PSYCHIATRY (2008)
The tools of the trade - An overview of the pharmacology of the endocannabinoid system
Christopher J. Fowler
CURRENT PHARMACEUTICAL DESIGN (2008)
Dopamine and Reward: The Anhedonia Hypothesis 30 years on
Roy A. Wise
NEUROTOXICITY RESEARCH (2008)
Retrograde endocannabinoid signaling at striatal synapses requires a regulated postsynaptic release step
Louise Adermark et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
A comprehensive profile of brain enzymes that hydrolyze the endocannabinoid 2-arachidonoylglycerol
Jacqueline L. Blankman et al.
CHEMISTRY & BIOLOGY (2007)
Reciprocal effects of response contingent and noncontingent intravenous heroin on in vivo nucleus accumbens shell versus core dopamine in the rat: a repeated sampling microdialysis study
Daniele Lecca et al.
PSYCHOPHARMACOLOGY (2007)
The cannabinoid CB1 receptor antagonist, rimonabant, as a promising pharmacotherapy for alcohol dependence:: Preclinical evidence
Giancarlo Colombo et al.
MOLECULAR NEUROBIOLOGY (2007)
Specific alterations of extracellular endocannabinoid levels in the nucleus accumbens by ethanol, heroin, and cocaine self-administration
Stephanie Caille et al.
JOURNAL OF NEUROSCIENCE (2007)
Differential neurochemical and behavioral adaptation to cocaine after response contingent and noncontingent exposure in the rat
Daniele Lecca et al.
PSYCHOPHARMACOLOGY (2007)
Bidirectional regulation of mu-opioid and CB1-cannabinoid receptor in rats self-administering heroin or WIN 55,212-2
Liana Fattore et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2007)
N-arachidonoyl-dopamine tunes synaptic transmission onto dopaminergic neurons by activating both cannabinoid and vanilloid receptors
Silvia Marinelli et al.
NEUROPSYCHOPHARMACOLOGY (2007)
Cannabinoid self-administration increases dopamine release in the nucleus accumbens
Paola Fadda et al.
NEUROREPORT (2006)
Monitoring extracellular dopamine in the rat nucleus accumbens shell and core during acquisition and maintenance of intravenous WIN 55,212-2 self-administration
Daniele Lecca et al.
PSYCHOPHARMACOLOGY (2006)
Anandamide administration alone and after inhibition of fatty acid amide hydrolase (FAAH) increases dopamine levels in the nucleus accumbens shell in rats
Marcello Solinas et al.
JOURNAL OF NEUROCHEMISTRY (2006)
Cannabinoid modulation of opiate reinforcement through the ventral striatopallidal pathway
S Caillé et al.
NEUROPSYCHOPHARMACOLOGY (2006)
Preferential increase of extracellular dopamine in the rat nucleus accumbens shell as compared to that in the core during acquisition and maintenance of intravenous nicotine self-administration
D Lecca et al.
PSYCHOPHARMACOLOGY (2006)
The endocannabinoid system as an emerging target of pharmacotherapy
Pal Pacher et al.
PHARMACOLOGICAL REVIEWS (2006)
The endogenous cannabinoid anandamide and its synthetic analog R(+)-methanandamide are intravenously self-administered by squirrel monkeys
Z Justinova et al.
JOURNAL OF NEUROSCIENCE (2005)
CB1 receptor knockout mice display reduced ethanol-induced conditioned place preference and increased striatal dopamine D2 receptors
H Houchi et al.
NEUROPSYCHOPHARMACOLOGY (2005)
In vivo neurochemical monitoring and the study of behaviour
M Fillenz
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2005)
Endocannabinoids mediate presynaptic inhibition of glutamatergic transmission in rat ventral tegmental area dopamine neurons through activation of CB1 receptors
M Melis et al.
JOURNAL OF NEUROSCIENCE (2004)
Reduced cellular expression and activity of the P129T mutant of human fatty acid amide hydrolase: evidence for a link between defects in the endocannabinoid system and problem drug use
KP Chiang et al.
HUMAN MOLECULAR GENETICS (2004)
Marijuana and cannabinoid regulation of brain reward circuits
CR Lupica et al.
BRITISH JOURNAL OF PHARMACOLOGY (2004)
Segregation of two endocannabinoid-hydrolyzing enzymes into pre- and postsynaptic compartments in the rat hippocampus, cerebellum and amygdala
AI Gulyas et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2004)
Dopamine and drug addiction: the nucleus accumbens shell connection
G Di Chiara et al.
NEUROPHARMACOLOGY (2004)
SR141716A reduces the reinforcing properties of heroin but not heroin-induced increases in nucleus accumbens dopamine in rats
S Caillé et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2003)
Self-administration of Δ9-tetrahydrocannabinol (THC) by drug naive squirrel monkeys
Z Justinova et al.
PSYCHOPHARMACOLOGY (2003)
The cannabinoid CB1 antagonist N-piperidinyl-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methylpyrazole-3-carboxamide (SR-141716A) differentially alters the reinforcing effects of heroin under continuous reinforcement, fixed ratio, and progressive ratio schedules of drug self-administration in rats
M Solinas et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2003)
Chronic morphine modulates the contents of the endocannabinoid, 2-arachidonoyl glycerol, in rat brain
D Viganò et al.
NEUROPSYCHOPHARMACOLOGY (2003)
Cardiovascular effects of methylphenidate in humans are associated with increases of dopamine in brain and of epinephrine in plasma
ND Volkow et al.
PSYCHOPHARMACOLOGY (2003)
Cannabinoid CB1 receptor knockout mice exhibit markedly reduced voluntary alcohol consumption and lack alcohol-induced dopamine release in the nucleus accumbens
BL Hungund et al.
JOURNAL OF NEUROCHEMISTRY (2003)
The cannabinoid CB1 antagonists SR 141716A and AM 251 suppress food intake and food-reinforced behavior in a variety of tasks in rats
PJ McLaughlin et al.
BEHAVIOURAL PHARMACOLOGY (2003)
The endogenous cannabinoid, anandamide, activates the hypothalamo-pituitary-adrenal axis in CB1 cannabinoid receptor knockout mice
T Wenger et al.
NEUROENDOCRINOLOGY (2003)
Nucleus accumbens shell and core dopamine: differential role in behavior and addiction
G Di Chiara
BEHAVIOURAL BRAIN RESEARCH (2002)
Brain reward circuitry: Insights from unsensed incentives
RA Wise
NEURON (2002)
Chemical stability of 2-arachidonylglycerol under biological conditions
CA Rouzer et al.
CHEMISTRY AND PHYSICS OF LIPIDS (2002)
Brain monoglyceride lipase participating in endocannabinoid inactivation
TP Dinh et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Augmentation of drug reward by chronic food restriction: Behavioral evidence and underlying mechanisms
KD Carr
PHYSIOLOGY & BEHAVIOR (2002)
A missense mutation in human fatty acid amide hydrolase associated with problem drug use
JC Sipe et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Endocannabinoid levels in rat limbic forebrain and hypothalamus in relation to fasting, feeding and satiation: stimulation of eating by 2-arachidonoyl glycerol
TC Kirkham et al.
BRITISH JOURNAL OF PHARMACOLOGY (2002)
Biosynthesis and degradation of anandamide and 2-arachidonoylglycerol and their possible physiological significance
T Sugiura et al.
PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS (2002)
Self-administration behavior is maintained by the psychoactive ingredient of marijuana in squirrel monkeys
G Tanda et al.
NATURE NEUROSCIENCE (2000)
Biochemistry and pharmacology of the endocannabinoids arachidonylethanolamide and 2-arachidonylglycerol
CJ Hillard
PROSTAGLANDINS & OTHER LIPID MEDIATORS (2000)
Share Paper
